News

Vitamin D analog shuts down pancreatic cancer’s shield in clinical trial

TGIF2-mediated HMGB3 overexpression drives oesophageal squamous cell carcinoma (ESCC)

ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST

ASCO 2026: Personalised vaccine boosts immune activity against brain cancer

Sacituzumab govitecan receives positive CHMP opinion in first-line metastatic triple-negative Breast cancer

Positive EU CHMP opinion for pembrolizumab in combination with enfortumab vedotin-ejfv as perioperative treatment in muscle-invasive bladder cancer

Cholesterol-craving cancers need lipid enzymes to use metabolites for growth

Researchers identify new indicator for response to therapy in pediatric cancers

ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers

ASCO 2026: Fasting before and after chemo may help improve treatment response for some people with ovarian cancer

ASCO 2026: Weight loss programme improves physical function, quality of life for patients with breast cancer

ASCO 2026: Less cognitive decline with darolutamide treatment than enzalutamide in people with advanced prostate cancer